• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Axikin Pharmaceuticals

edit

Axikin Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused exclusively on the development and commercialization of small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory dermatoses, inflammatory bowel disease and rheumatoid arthritis. Axikin was spun out from Actimis Pharmaceuticals, in June 2008.

Recent Milestones

edit

• 
  Axikin Pharmaceuticals received $3M in Series A funding. (1/22/09)
  Posted 6/20/09 at 8:28pm via reuters.com
• 
  Axikin Pharmaceuticals added Kevin B. Bacon, Ph.D. as President, Founder and Chief Scientific Officer.
  Posted 6/20/09 at 8:25pm
• 
  Axikin Pharmaceuticals added Peter McWilliams, Ph.D. as Chairman and Acting Chief Executive Officer.
  Posted 6/20/09 at 8:25pm

Videos

Screenshots

edit

Above: Axikin Pharmaceuticals Screenshot -- #1
Uploaded: 6/21/09

Sources

1. Axikin Pharmaceuticals Spins out of Actimis (reuters.com) [edit]